Spend $99, get free U.S. shipping*

Important Update: We’re open, but due to the security situation in Israel, some delays in shipping and customer support are expected.
We’ll keep things moving as best we can. Thanks for standing with us.

For visual reference only; actual product may vary

  • US Name:

    Nubeqa

  • Alternative Names:

    Nubeqa

  • Active Ingredients:

    Darolutamide

  • Brand Manufacturer:

  • Manufacturer Location:

  • Click here to view Product Insert

  • Click here to view Product Insert

Nubeqa *

For visual reference only; actual product may vary

Prescription Required
All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

Nubeqa is approved for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC).

Place your order

Nubeqa Brand 300mg
120 Tablets
-
+
Our price:
$4,550.00

*Please note all prices are in US dollars

Nubeqa (generic name: darolutamide) is an androgen receptor inhibitor used in the treatment of adult men with either non-metastatic castration-resistant prostate cancer (nmCRPC) or metastatic hormone-sensitive prostate cancer (mHSPC). In cases of mHSPC, Nubeqa may be used in combination with docetaxel, which is a chemotherapy medication used to treat several types of cancer.

Darolutamide works by blocking the action of androgens, including testosterone, which are male sex hormones that can promote the growth of prostate cancer cells. Inhibiting the androgen receptor slows down or halts the proliferation of cancer cells.

Nubeqa is designed to be well-tolerated, even when used alongside other prostate cancer treatments. It has been shown to delay disease progression and prolong survival.

Caution

Nubeqa can cause birth defects. Men should use effective contraception when engaging in sex with a fertile woman when starting treatment with Nubeqa and for at least one week after treatment stops.

Dosage

Take the medicine exactly as outlined on the label and in accord with the prescribing doctor’s instructions. The tablets should be taken at the same time each day, and the dosing schedule should be maintained consistently. Treatment with Nubeqa should not be discontinued without medical advice.

The usual dose of Nubeqa is two 300 mg tablets twice daily. The tablets should be taken with food and swallowed whole with a full glass of water. Do not split, chew or crush them. In cases where the patient has liver or kidney impairment, a doctor may reduce the dose to one 300 mg tablet twice daily.

This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication. 

Read the information leaflet that comes with the medication.

Most people who use Nubeqa do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.

Some of the side effects that have been reported include rashes, fatigue, anemia, and some disturbances of blood chemistry and liver function. Doctors usually monitor for these changes with regular blood tests.

Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.

Nubeqa is approved for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC).

nmCRPC refers to prostate cancer that no longer responds to testosterone-lowering therapies and has not yet spread to other parts of the body. Common symptoms include frequent or painful urination, blood in urine or semen, erectile dysfunction, and pelvic discomfort. Despite being non-metastatic, the cancer is aggressive and continues to progress without visible metastases.

mHSPC is a stage of prostate cancer that has spread (metastasized) but still responds to hormone therapy. Symptoms may include bone pain, unexplained weight loss, fatigue, and urinary obstruction. In mHSPC, Nubeqa is often used in combination with chemotherapy agents like docetaxel to enhance outcomes.

  • Nubeqa is an androgen receptor inhibitor that binds to androgen receptors inside prostate cancer cells, preventing testosterone from fueling cancer growth and slowing disease progression .

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Fast delivery
Secure payment
Genuine brands
Pharmacist oversight
Proudly Israeli

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Read more from our blog

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email